The Life Sciences ReportStreetwise Reports
Join InvestorPlace Insights — FREE!
Get actionable advice from our top experts, including the hottest stocks to buy & sell, 401k and retirement tips, market analysis and more!
SeeThruEquity's Ajay Tandon and Jay Albany are riding the biotech bull by harnessing the huge upside potential of these micro-cap companies
Sunesis Pharmaceuticals' Vosaroxin will be leading the charge, hopefully gaining regulatory traction both in the U.S. and the European Union.
In the next two to three years, we are going to see whether we really can fix diseases by driving the body to do the repairs, instead of adding products into the body to handle the symptoms of disease.